Skip to main content

Peer Review reports

From: Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

Original Submission
7 Dec 2021 Submitted Original manuscript
5 May 2022 Author responded Author comments - Thomas Lehnert
Resubmission - Version 2
5 May 2022 Submitted Manuscript version 2
28 May 2022 Editorially accepted
1 Jul 2022 Article published 10.1186/s13643-022-01997-2

You can find further information about peer review here.

Back to article page